Tag: Corporate News

  • Life Healthcare Declares 235c Dividend for Investors

    Private hospital group Life Healthcare has delighted investors by declaring a special cash dividend of 235c per share. This move follows the finalised disposal of the group’s entire interest in its Life Molecular Imaging (LMI) business to Lantheus Radiopharmaceuticals UK. The JSE-listed group confirmed the landmark R13.9bn deal. They committed to returning the proceeds directly to shareholders. Management anticipated closing…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Adcock Ingram to Delist Amidst Corporate Changes

    Adcock Ingram, the pharmaceutical giant behind household brands such as Panado and Corenza-C, could delist from the Johannesburg Stock Exchange (JSE). This follows a significant deal between its majority shareholder, Bidvest, and Indian drugmaker Natco Pharma. The news saw Adcock’s share price surge by 24%. Under the terms of the agreement, Indian-listed Natco Pharma will acquire a significant minority stake…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Dis-Chem Grapples with Retail Squeeze and Fierce Competition

    Pharmacy and retail giant Dis-Chem is facing a dual threat to its growth ambitions: a critical shortage of suitable retail space. Additionally, the company disclosed in its latest annual report that there is intensifying competition across the healthcare and consumer sectors. The group identified the limited availability of profitable locations as a key risk to its core expansion strategy. This…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in